Biotech

All Articles

Bicara, Zenas seek IPOs to push late-phase properties toward market

.Bicara Therapies and also Zenas Biopharma have actually delivered fresh impetus to the IPO market a...

Genentech to finalize cancer immunology research study team

.Genentech will shut its own cancer cells immunology investigation team, and also system head as wel...

Kezar loses strong cyst however to verify its own truly worth in stage 1 test

.Kezar Life Sciences is actually falling its own unpromising period 1 sound tumor medicine as the bi...

Acelyrin drops izokibep, lays off 3rd of team

.Despite izokibep keeping its own newfound winning touch in the center, Acelyrin is actually no more...

Rivus' phase 2 obesity-related cardiac arrest trial reaches endpoint

.Rivus Pharmaceuticals has plumped up the leads of its own fat-busting, muscle-sparing medication ca...

Ovid stops preclinical work, IV plan after soticlestat fall short

.Ovid Therapeutics currently revealed last month that it was actually trimming back its head count a...

Eli Lilly opens $700M nucleic acid R&ampD facility in Boston ma Seaport

.Eli Lilly has opened a $700 thousand R&ampD center in the Boston Port, improving its RNA as well as...

Boundless Bio produces 'small' discharges 5 months after $100M IPO

.Just five months after securing a $100 thousand IPO, Vast Biography is actually already laying off ...

Halda's $126M will accelerate 'keep and get rid of' cyst drugs

.The preliminary phases of oncology R&ampD may not be except interesting brand-new methods, and Hald...

Lykos 'regrets' certainly not revealing study offenses along with author

.Psychopharmacology has actually taken 3 posts about midstage medical trial data assessing Lykos The...